Old Web
English
Sign In
Acemap
>
authorDetail
>
V. Piolat
V. Piolat
Medicine
Pathology
Internal medicine
Vinorelbine
Randomized controlled trial
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
French experience of patient management when receiving oral vinorelbine chemotherapy (NVBO) for metastatic breast cancer: Final results of a prospective observational survey on practices
2016
Journal of Clinical Oncology
J Lotz
F. Husseini
M. Finck
M. Rotarski
L. Bastit
A. Riviere
A. Youssef
J. Mouysset
S. Nahon
V. Piolat
Show All
Source
Cite
Save
Citations (1)
A fractionated schedule of oral vinorelbine (NVBo) with cisplatin (CDDP) concomitantly with radiotherapy (RT) after induction chemotherapy (CT) in locally advanced (LA) non-small cell lung cancer (NSCLC): Safety and efficacy results of a phase II trial
2009
Journal of Clinical Oncology
Delphine Lerouge
Radj Gervais
Eric Dansin
C. Dujon
C. Chouaid
A. Riviere
B. Precheur-Agulhon
V. Piolat
Gérard Zalcman
Eric Lartigau
Show All
Source
Cite
Save
Citations (0)
727 A phase II study of CPT 11 (irinotecan) in refractory to 5 FU colorectal cancer (CRC) with, preventive treatment of delayed diarrhea by acetorphan
1995
European Journal of Cancer
Yacine Merrouche
Roland Bugat
R. Brunet
J.-F. Seitz
Thierry Conroy
V. Fabre
Moïse Namer
V. Piolat
M. Mahjoubi
Jean Pierre Droz
Show All
Source
Cite
Save
Citations (0)
1